Related Experiment Video
Updated: Mar 28, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Proton Pump Inhibitors and the Prescribing Cascade
Many nursing home residents take proton pump inhibitors (PPIs) long-term, often unnecessarily. Increased anticholinergic burden and polypharmacy significantly predict PPI use, suggesting a prescribing cascade.
Area of Science:
- Geriatric Pharmacology
- Medication Safety
- Clinical Pharmacy
Background:
- Proton pump inhibitors (PPIs) are widely prescribed in nursing home residents.
- Long-term PPI use is common and often exceeds recommended durations.
- The prescribing cascade, where drug-induced symptoms lead to new prescriptions, may contribute to PPI overuse.
Purpose of the Study:
- To describe the prescribing cascade of PPIs in nursing home residents.
- To identify factors associated with PPI and H2 receptor blocker use in this population.
Main Methods:
- Retrospective analysis of 248 nursing home residents' medication data.
- Logistic regression modeling to identify significant predictors of PPI use.
Main Results:
- Ninety-three percent of residents on PPIs had prescriptions exceeding recommended durations.
- Higher anticholinergic burden (p=0.031) and increased number of oral products (polypharmacy) (p=0.04) were significant predictors of PPI use.
- These factors may be linked to polypharmacy-associated dyspepsia and anticholinergic effects on esophageal pressure.
Conclusions:
- High PPI utilization in nursing homes may indicate a prescribing cascade.
- Strategies to mitigate polypharmacy and anticholinergic burden could reduce inappropriate PPI use.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
05:50Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Depolarizing Blockers: Pharmocokinetics